- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06047730
Clinical Effect Evaluation of Laparoscopic Surgery for Ovarian Benign Tumors by Different Approaches
September 14, 2023 updated by: Yingchun Ma
Main purpose: To compare the intraoperative and postoperative recovery of laparoscopic surgery for ovarian benign tumors through different approaches; Secondary objective: Will vNOTES increase the risk of cesarean section during pregnancy and affect the quality of sexual life after surgery.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
173
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Shandong
-
Jinan, Shandong, China
- Qianfoshan Hospital, The First Hospital affiliated of Shandong First Medical University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
nothing
Description
Inclusion Criteria:
Preoperative consideration was for benign ovarian tumors requiring surgical treatment.
Exclusion Criteria:
- (1) Ovarian malignant tumor or borderline tumor was considered before surgery or proved during surgery. (2) Severe endometriosis, previous severe pelvic inflammation, peritonitis, and other serious pelvic adhesions are considered. (3) Pregnancy status. (4) Postoperative follow-up is not convenient and lost visitors.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
multi-port laparoscopic surgery
|
nothing
|
|
transumbilical laparoendoscopic single-site surgery
|
nothing
|
|
vaginal natural orifice transluminal endoscopic surgery
|
nothing
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
peroperative bleeding
Time Frame: during the operation time
|
peroperative bleeding
|
during the operation time
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
postoperative exhaust time
Time Frame: within 3 days after operation
|
postoperative exhaust time
|
within 3 days after operation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2017
Primary Completion (Actual)
July 1, 2022
Study Completion (Actual)
March 31, 2023
Study Registration Dates
First Submitted
September 14, 2023
First Submitted That Met QC Criteria
September 14, 2023
First Posted (Actual)
September 21, 2023
Study Record Updates
Last Update Posted (Actual)
September 21, 2023
Last Update Submitted That Met QC Criteria
September 14, 2023
Last Verified
September 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Neoplasms
- Urogenital Neoplasms
- Neoplasms by Site
- Genital Neoplasms, Female
- Endocrine System Diseases
- Ovarian Diseases
- Adnexal Diseases
- Gonadal Disorders
- Endocrine Gland Neoplasms
- Female Urogenital Diseases
- Female Urogenital Diseases and Pregnancy Complications
- Urogenital Diseases
- Genital Diseases
- Genital Diseases, Female
- Ovarian Neoplasms
Other Study ID Numbers
- V50KFC
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Laparoscope
-
Menoufia UniversityCompletedIntraperitoneal Magnesium Sulphate in Laparoscope in PediatricsEgypt
Clinical Trials on operation ways
-
Canterbury Christ Church UniversityInterreg 2 Seas Mers ZeeenWithdrawn
-
Norwegian Institute of Public HealthThe Dam FoundationRecruitingQuality of Life | Wellbeing | Mental Health Wellness 1Norway
-
Hôpital NOVOCompleted
-
Child TrendsFamily and Youth Services Bureau; Latin American Youth Center; Equimundo:Center...Recruiting
-
University of KonstanzCompletedAggression | Depression | PTSDUganda
-
University Hospital of SplitCompletedInflammatory Response | Surgery | Children, Only | C Reactive Protein | Inguinal Hernia, Indirect | Interleukin-6 | Tumor Necrosis Factor Alpha | White Blood Cell Count, LeukocytesCroatia
-
State Budget Public Health Institution Scientific...RecruitingParastomal HerniaRussia
-
Reading Health SystemRecruiting
-
Assiut UniversityCompletedAortic Root Aneurysm | Aortic Root DissectionEgypt
-
Peking University Third HospitalRecruitingAnkle Sprains | Instability, Joint | Joint HypermobilityChina